Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Arsenal Capital Acquires Certara | Contract Pharma
Breaking News

Arsenal Capital Acquires Certara

Invests in R&D data analytics market

Arsenal Capital Partners, a NY-based private equity firm, has acquired Certara, a provider of model-based drug development and data analytics software and consulting services to the biopharma R&D market.
 
Certara provides integrated solutions consisting of computer-based models supported by scientific consulting services that span the discovery, preclinical and clinical stages of drug development. Certara’s solutions aim to provide clients with reductions in the time and expense of bringing new drugs to market by enabling data-driven decisions.
 
Stephen McLean, a partner at Arsenal and co-head of the firm’s Healthcare Group, said, “We are delighted to invest in this exciting company which is making such an important contribution to improving the productivity of the drug development process. The average cost today of researching and developing a new drug is more than $1.5 billion and takes 10-15 years. This is clearly inconsistent with the imperative of reducing the costs of global healthcare and Certara will make a difference.”
 
Jim Hopkins, Certara’s chief executive officer, commented, “Arsenal shares our vision for applying analytics and scientific informatics to facilitate the distribution of pharmaceutical knowledge. After careful assessment, we were impressed with Arsenal’s deep understanding of our mission and our value. We are confident that this is the right match for Certara and one that will benefit both our customers and staff.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters